The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).
 
Luis G. Paz-Ares
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Alexander Luft
No Relationships to Disclose
 
Ali Tafreshi
No Relationships to Disclose
 
Mahmut Gumus
No Relationships to Disclose
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly/ImClone; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Barbara Hermes
No Relationships to Disclose
 
Filiz Cay Senler
No Relationships to Disclose
 
Andrea Fülöp
No Relationships to Disclose
 
Jeronimo Rodriguez-Cid
No Relationships to Disclose
 
Shunichi Sugawara
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Kyowa Hakko Kirin; Lilly; MSD K.K; Nippon Boehringer Ingelheim; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
 
Ying Cheng
No Relationships to Disclose
 
Silvia Novello
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Balazs Halmos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; Novartis; Pfizer; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim; Merck; Mirati Therapeutics; Pfizer; Roche/Genentech; Takeda
 
Yue Shentu
No Relationships to Disclose
 
Dariusz Kowalski
No Relationships to Disclose